1. Home
  2. CPOP vs CTXR Comparison

CPOP vs CTXR Comparison

Compare CPOP & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pop Culture Group Co. Ltd

CPOP

Pop Culture Group Co. Ltd

HOLD

Current Price

$0.12

Market Cap

18.8M

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.57

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPOP
CTXR
Founded
2007
2007
Country
China
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
18.9M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
CPOP
CTXR
Price
$0.12
$0.57
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
27.3M
426.4K
Earning Date
11-17-2025
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.38
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.48
52 Week High
$2.60
$2.24

Technical Indicators

Market Signals
Indicator
CPOP
CTXR
Relative Strength Index (RSI) 44.36 43.43
Support Level N/A $0.48
Resistance Level $0.51 $0.74
Average True Range (ATR) 0.32 0.04
MACD -0.05 0.00
Stochastic Oscillator 0.41 22.86

Price Performance

Historical Comparison
CPOP
CTXR

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: